|
US5171680A
(en)
|
1988-06-14 |
1992-12-15 |
Chiron Corporation |
Superoxide dismutase analogs having novel binding properties
|
|
DK0608235T4
(da)
|
1991-11-13 |
2005-05-30 |
A C Thrombosis And Coagulati T |
Fremgangsmåde til diagnose af blodkoagulationssygdomme
|
|
US5670483A
(en)
|
1992-12-28 |
1997-09-23 |
Massachusetts Insititute Of Technology |
Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
|
|
JP3367581B2
(ja)
|
1993-10-14 |
2003-01-14 |
小野薬品工業株式会社 |
新規なポリペプチド、その製造方法、そのポリペプチドをコードするｄｎａ、そのｄｎａからなるベクター、そのベクターで形質転換された宿主細胞
|
|
US6852508B1
(en)
|
1997-02-28 |
2005-02-08 |
Genetics Institute, Llc |
Chemokine with amino-terminal modifications
|
|
US6100387A
(en)
|
1997-02-28 |
2000-08-08 |
Genetics Institute, Inc. |
Chimeric polypeptides containing chemokine domains
|
|
US6214540B1
(en)
|
1997-03-26 |
2001-04-10 |
University Of Maryland Biotechnology Institute |
Chemokines that inhibit immunodeficiency virus infection and methods based thereon
|
|
CA2245224A1
(en)
|
1998-08-14 |
2000-02-14 |
Jiang-Hong Giong |
Chemokine receptor antagonists and chemotherapeutics
|
|
DE69914463T2
(de)
|
1998-03-13 |
2004-11-11 |
The University Of British Columbia, Vancouver |
Therapeutische chemokine rezeptor antagonisten
|
|
CA2305787A1
(en)
|
2000-05-09 |
2001-11-09 |
The University Of British Columbia |
Cxcr4 antagonist treatment of hematopoietic cells
|
|
US20020107195A1
(en)
|
1998-07-21 |
2002-08-08 |
Smithkline Beecham Corporation |
Method for inducing chemotaxis in endothelial cells by administering stromal cell derived factor-1alpha
|
|
US6440934B1
(en)
*
|
1998-10-13 |
2002-08-27 |
Chiron Corporation |
Angiogenically effective unit dose of FGF-2 and method of use
|
|
AU766190B2
(en)
*
|
1998-10-16 |
2003-10-09 |
Biogen Idec Ma Inc. |
Interferon-beta fusion proteins and uses
|
|
US6221856B1
(en)
|
1999-02-03 |
2001-04-24 |
Inologic, Inc. |
Inositol derivatives for inhibiting superoxide anion production
|
|
AU2003901668A0
(en)
|
2003-03-28 |
2003-05-01 |
Medvet Science Pty. Ltd. |
Non-haemopoietic precursor cells
|
|
CA2335109A1
(en)
|
2000-04-12 |
2001-10-12 |
Chemokine Therapeutics Corporation |
Cxcr4 agonist treatment of hematopoietic cells
|
|
US7368425B2
(en)
|
2006-03-24 |
2008-05-06 |
Chemokine Therapeutics Corp. |
Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis
|
|
US20050059584A1
(en)
|
2002-08-16 |
2005-03-17 |
Ahmed Merzouk |
Novel chemokine mimetics synthesis and their use
|
|
US7378098B2
(en)
|
2000-04-12 |
2008-05-27 |
The University Of British Columbia |
CXC chemokine receptor 4 agonist peptides
|
|
DE10027383A1
(de)
|
2000-06-02 |
2001-12-20 |
Rhein Biotech Proz & Prod Gmbh |
Nukleinsäure-Molekül umfassend eine für ein Chemokin, einen Neuropeptid-Präkursor oder mindestens ein Neuropeptid kodierende Nukleinsäuresequenz
|
|
EP2324839B1
(en)
|
2000-06-05 |
2017-08-09 |
The Trustees of Columbia University in the City of New York |
Granulocyte-colony-stimulating-factor (g-csf) for use in the treatment of myocardial infarct
|
|
US7547674B2
(en)
|
2001-06-06 |
2009-06-16 |
New York Medical College |
Methods and compositions for the repair and/or regeneration of damaged myocardium
|
|
US20020094327A1
(en)
|
2000-11-05 |
2002-07-18 |
Petersen Bryon E. |
Targeting pluripotent stem cells to tissues
|
|
EP1335744A2
(en)
|
2000-11-09 |
2003-08-20 |
Genetics Institute, LLC |
Sdf-1 beta expressing tumor cells as tumor vaccines
|
|
US20020111290A1
(en)
|
2000-12-01 |
2002-08-15 |
Bernhard Homey |
Uses of mammalian genes and related reagents
|
|
US20020156023A1
(en)
|
2000-12-06 |
2002-10-24 |
Tularik Inc. |
Lometrexol combination therapy
|
|
AU2002348241A1
(en)
|
2001-11-24 |
2003-06-10 |
Image Analysis, Inc. |
Automatic detection and quantification of coronary and aortic calcium
|
|
US20030199464A1
(en)
|
2002-04-23 |
2003-10-23 |
Silviu Itescu |
Regeneration of endogenous myocardial tissue by induction of neovascularization
|
|
WO2003094950A2
(en)
|
2002-05-10 |
2003-11-20 |
Ipf Pharmaceuticals Gmbh |
A method of inhibiting the emigration of cells from the intravascular compartment into tissues
|
|
US7485141B2
(en)
|
2002-05-10 |
2009-02-03 |
Cordis Corporation |
Method of placing a tubular membrane on a structural frame
|
|
US20050065064A1
(en)
|
2002-08-09 |
2005-03-24 |
Elias Lolis |
Identification of allosteric peptide agonists of CXCR4
|
|
US20050271639A1
(en)
|
2002-08-22 |
2005-12-08 |
Penn Marc S |
Genetically engineered cells for therapeutic applications
|
|
US20040037811A1
(en)
|
2002-08-22 |
2004-02-26 |
The Cleveland Clinic Foundation |
Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy
|
|
JP2006502142A
(ja)
|
2002-08-23 |
2006-01-19 |
ブリストル−マイヤーズ スクイブ カンパニー |
虚血性損傷を減少させる方法
|
|
US20070060512A1
(en)
|
2003-03-04 |
2007-03-15 |
Homayoun Sadeghi |
Dipeptidyl-peptidase protected protein
|
|
WO2004094465A2
(en)
|
2003-04-23 |
2004-11-04 |
The Board Of Trustees Of The University Of Illinois Office Of Technology Management University Of Illinois At Urbana-Champaign |
Synthetic molecules that mimic chemokines
|
|
US7776564B2
(en)
|
2004-04-30 |
2010-08-17 |
Five Prime Therapeutics, Inc. |
Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use
|
|
WO2006030887A1
(ja)
|
2004-09-17 |
2006-03-23 |
Cellgentech, Inc. |
外用皮膚潰瘍治療剤
|
|
CN101103101B
(zh)
|
2004-09-24 |
2012-10-10 |
成血管细胞系统公司 |
增强间充质前体细胞（mpc）的增生和/或存活的方法
|
|
US7399831B2
(en)
|
2004-10-25 |
2008-07-15 |
The Brigham And Women's Hospital, Inc. |
Targeted delivery of biological factors using self-assembling peptide nanofibers
|
|
US20060110374A1
(en)
|
2004-11-24 |
2006-05-25 |
Dudy Czeiger |
Method to accelerate stem cell recruitment and homing
|
|
AU2005323062A1
(en)
|
2005-01-04 |
2006-07-13 |
The Brigham And Women's Hospital, Inc. |
Sustained delivery of PDGF using self-assembling peptide nanofibers
|
|
WO2006074464A2
(en)
|
2005-01-10 |
2006-07-13 |
Mayo Foundation For Medical Education And Research |
Modulating toll-like receptor activity
|
|
KR20100102750A
(ko)
|
2005-04-25 |
2010-09-24 |
메사추세츠 인스티튜트 오브 테크놀로지 |
지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및 방법
|
|
WO2007051785A2
(en)
*
|
2005-10-31 |
2007-05-10 |
Laboratoire Serono S.A. |
Use of sdf-1 for the treatment and/or prevention of neurological diseases
|
|
WO2007079460A2
(en)
|
2006-01-04 |
2007-07-12 |
Chemokine Therapeutics Corporation |
Design of cxc chemokine analogs for the treatment of human diseases
|
|
US7776816B2
(en)
|
2006-01-20 |
2010-08-17 |
Board Of Regents, The University Of Texas System |
Preserving hypoxic tissue
|
|
JP5244785B2
(ja)
|
2006-08-11 |
2013-07-24 |
小野薬品工業株式会社 |
ストローマ由来因子−１（ｓｄｆ−１）に対するモノクローナル抗体
|
|
US7696309B2
(en)
|
2006-10-23 |
2010-04-13 |
The Brigham And Women's Hospital, Inc. |
Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
|
|
US20080194478A1
(en)
|
2007-02-09 |
2008-08-14 |
Gene Signal International Sa |
Wound healing agent and composition
|
|
ES2520044T3
(es)
|
2007-03-30 |
2014-11-11 |
The Cleveland Clinic Foundation |
SDF-1 para su uso en el tratamiento de trastornos vasculares periféricos isquémicos
|
|
ES2325715B1
(es)
|
2007-08-03 |
2010-06-17 |
Genetrix, S.L. |
Poblacion de celulas madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneracion cardiaca.
|
|
US8414924B2
(en)
|
2007-10-10 |
2013-04-09 |
Kyoto University |
Preparation for treating heart disease used in cell therapy
|
|
ATE543507T1
(de)
*
|
2007-11-07 |
2012-02-15 |
Ono Pharmaceutical Co |
Sdf-1 enthaltende zusammensetzung mit anhaltender freisetzung
|
|
EP2100954A1
(en)
|
2008-03-10 |
2009-09-16 |
Assistance Publique - Hopitaux de Paris |
Method for generating primate cardiac progenitor cells for clinical use from primate embryonic stem cells, and their applications
|
|
WO2010024300A1
(ja)
|
2008-08-26 |
2010-03-04 |
国立大学法人 北海道大学 |
骨充填型軟骨組織再生誘導剤
|
|
KR20120047214A
(ko)
|
2009-05-20 |
2012-05-11 |
보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템 |
심근경색 후 리모델링 및 심부전에 관련된 마이크로―ｒｎａ의 확인
|
|
WO2010138180A2
(en)
*
|
2009-05-26 |
2010-12-02 |
The University Of Vermont And State Agriculture College |
Compositions and methods for cardiac tissue repair
|
|
WO2011106234A1
(en)
*
|
2010-02-25 |
2011-09-01 |
Provasculon, Inc. |
Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
|
|
WO2012027170A1
(en)
*
|
2010-08-23 |
2012-03-01 |
Provasculon, Inc. |
Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1
|
|
WO2012026041A1
(ja)
*
|
2010-08-27 |
2012-03-01 |
富士通株式会社 |
並列計算機、並列計算機のジョブ情報取得プログラム、並列計算機のジョブ情報取得方法、計算装置及び計算管理装置
|
|
JP6145089B2
(ja)
|
2011-06-07 |
2017-06-07 |
メソブラスト インターナショナル エスエイアールエル |
ストロマ細胞由来因子−１のプロテアーゼ耐性変異体を用いた、組織損傷を修復するための方法
|
|
AU2014362198A1
(en)
|
2013-12-13 |
2016-07-07 |
Mesoblast International Sarl |
Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1
|